Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test | Curated by Alerts360

Nov 20, 2025 - 19:35

0

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test | Curated by Alerts360

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences. Stay informed with the latest market updates, stock movements, and financial news to make timely decisions.

Continue Reading

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Why bitcoin’s brutal drop from an October record high is now a crucial barometer for the broader market | Curated by Alerts360

Why bitcoin’s brutal drop from an October record high i...

Nov 22, 2025 0

Sovereign Bitcoin adoption would be the ultimate upside catalyst: Jeff Park | Curated by Alerts360

Sovereign Bitcoin adoption would be the ultimate upside...

Nov 22, 2025 0

‘There’s a lot of tension’: My brother and I manage a $5 million trust. How do we solve our many disagreements? | Curated by Alerts360

‘There’s a lot of tension’: My brother and I manage a $...

Nov 22, 2025 0

Kyiv’s allies insist more work is needed on US-Russian peace plan | Curated by Alerts360

Kyiv’s allies insist more work is needed on US-Russian ...

Nov 22, 2025 0

Is Strategy Stock the Preferred Hedge Against Crypto Losses? Tom Lee Thinks So | Curated by Alerts360

Is Strategy Stock the Preferred Hedge Against Crypto Lo...

Nov 22, 2025 0

‘Extremely lucky’ solo Bitcoin miner beats massive odds to win $266K | Curated by Alerts360

‘Extremely lucky’ solo Bitcoin miner beats massive odds...

Nov 22, 2025 0